Cns Drug Designs, Actions, and Applications I
Explores how chemical properties influence CNS molecular targets and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes through altered signaling.
Summary
Recent recorded grades — Spring 2007: 3.77 GPA, 92.3% A/AB (n=13 letter grades).
What you’ll be able to do
Identify CNS active drug classes and origins of cholinergic and glutamatergic drugs based in part on structural aspects of the molecule.
List physicochemical properties of drugs, anatomical structures and molecular machinery that influence drug access to and efflux from the CNS.
Describe the major neurotransmitters of the central nervous system, including their physiologic role, distribution, synthesis, storage, and release.
Recall the principal mechanisms by which receptors affect cellular signaling in the Central Nervous System.
Match psychiatric conditions and target symptoms of these conditions with appropriate cholinergic and glutamatergic pharmaceuticals.
Describe common / serious adverse effects of cholinergic and glutamatergic pharmaceuticals and methods for preventing or minimizing their occurrence.
Source: UW Guide
Grade history
↗All recorded terms · compare terms & instructors
Prerequisites
Course mapDeclared in MS Pharmaceutical Sciences
“Used by” includes alternatives; linked courses may have other requirements. This is a best-effort interpretation; check the catalog requirements above.
Prerequisite text tree
- Declared in MS Pharmaceutical Sciences
Professors
Spring 2027No instructors recorded for this selection.
Historical instructors & teaching patterns
Recorded history may be incomplete and does not establish a future schedule.
Calendar & sections
Spring 2027Schedule loads here as you scroll.
| Section | Mode | Enrolled / capacity | Waitlist |
|---|
Times are Central. Select a meeting for details; export includes recorded dates for the selected sections.
Meeting source records
No records available.
Student experience
the class
Recent recorded grades — Spring 2007: 3.77 GPA, 92.3% A/AB (n=13 letter grades).
difficulty & workload
No workload feedback recorded.
Topics
- Major CNS neurotransmitters: role, distribution, synthesis, storage, and release
- Receptor mechanisms affecting cellular signaling in the CNS
- Adverse effects of cholinergic and glutamatergic pharmaceuticals and prevention methods
- Structural aspects of cholinergic and glutamatergic drugs and CNS active classes
Skills
- Primary literature analysis and conceptual integration across multiple biological levels
- Matching psychiatric conditions with appropriate cholinergic and glutamatergic pharmaceuticals
- Identifying physicochemical properties influencing CNS drug access and efflux
Grades
Latest available · Spring 2007— not enough history to project Spring 2027.
Grade distribution · % of letter grades
More grade details Grade mix, volume & source data
Not enough comparable courses for Spring 2027 in UW–Madison.
Sources & history
Catalog & offerings
Descriptions, prerequisites, and recorded course offerings.
Catalog observation history
Observations at scan time; dates do not imply when a catalog change took effect.
Selected offering source records
No offering records for the selected term.
Raw records
[]
Student reviews
Original comments behind the course and instructor summaries.
Read original reviews
No records available.
Grade history
Recorded grade distributions by term, section, and instructor.
Explore recorded gradesRecorded 2026-10-14
Model outputs & technical records
LLM outputs across runs
Full model traces
Recorded model configuration, reasoning, and tool conversations.
Model & dataset provenance
{
"model": "Qwen/Qwen3.8-27B",
"model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
"task_version": "17",
"output_id": "474c0fc18b92938c88cdfd25b8c7d1a3e7907d5d9a6c5a77041940051cd7e99d",
"requirements_status": "valid",
"dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
"observed_at": "2026-10-14 17:50:09.728220+00:00"
}